Key result
An epicardial-endocardial scar gradient >20% (horizontal scar) was independently associated with a higher incidence of fatal ventricular arrhythmias compared to transmural or intermediate scars.
Why the study?
Does the epicardial-endocardial scar gradient predict fatal ventricular arrhythmias in patients with ARVC?
Cohort (n=80)
Does the epicardial-endocardial scar gradient predict fatal ventricular arrhythmias in patients with ARVC?
In patients with ARVC, an epicardial-endocardial scar gradient extending horizontally rather than transmurally is independently associated with a higher risk of fatal ventricular arrhythmias.
May aid VA risk stratification in ARVC; leaves open prospective validation and therapeutic implications.
Aims: Whether the distribution of scar in arrhythmogenic right ventricular cardiomyopathy (ARVC) plays a role in predicting different types of ventricular arrhythmias is unknown. This study aimed to investigate the prognostic value of scar distribution in patients with ARVC. Methods and results: We studied 80 consecutive ARVC patients (46 men, mean age 47 ± 15 years) who underwent an electrophysiological study with ablation. Thirty-four patients receive both endocardial and epicardial mapping. Abnormal endocardial substrates and epicardial substrates were characterized. Three groups were defined according to the epicardial and endocardial scar gradient (<10%: transmural, 10-20%: intermediate, >20%: horizontal, as groups 1, 2, and 3, respectively). Sinus rhythm electrograms underwent a Hilbert-Huang spectral analysis and were displayed as 3D Simultaneous Amplitude Frequency Electrogram Transformation (SAFE-T) maps, which represented the arrhythmogenic potentials. The baseline characteristics were similar between the three groups. Group 3 patients had a higher incidence of fatal ventricular arrhythmias requiring defibrillation and cardiac arrest during the initial presentation despite having fewer premature ventricular complexes. A larger area of arrhythmogenic potentials in the epicardium was observed in patients with horizontal scar. The epicardial-endocardial scar gradient was independently associated with the occurrence of fatal ventricular arrhythmias after a multivariate adjustment. The total, ventricular tachycardia, and VF recurrent rates were higher in Group 3 during 38 ± 21 months of follow-up. Conclusion: For ARVC, the epicardial substrate that extended in the horizontal plane rather than transmurally provided the arrhythmogenic substrate for a fatal ventricular arrhythmia circuit.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2016) conducted a cohort in Arrhythmogenic right ventricular cardiomyopathy (ARVC) (n=80). Epicardial-endocardial scar gradient >20% (horizontal scar) vs. Scar gradient <10% (transmural) or 10-20% (intermediate) was evaluated on Fatal ventricular arrhythmias requiring defibrillation and cardiac arrest. An epicardial-endocardial scar gradient >20% (horizontal scar) was independently associated with a higher incidence of fatal ventricular arrhythmias compared to transmural or intermediate scars.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: